BioCentury
ARTICLE | Financial News

Genetic disease testing company Centogene raises €25M series A

July 7, 2017 8:09 PM UTC

On June 13, genetic disease diagnostic company Centogene AG (Rostock, Germany) raised €25 million ($28 million) in a series A round led by TVM Capital Life Sciences with participation by DPE Deutsche ...